March 04, 2014
Amarin Pharmaceuticals Ireland Ltd. on Tuesday hit AstraZeneca Pharmaceuticals LP with a lawsuit alleging that the company's heart medication Epanova will infringe on Amarin's patent for Vascepa, marking the second lawsuit within a week the company has filed to protect its rights to the triglyceride-reducing drug.